133 results on '"Zhang, Chris Zhiyi"'
Search Results
2. HnRNPR-mediated UPF3B mRNA splicing drives hepatocellular carcinoma metastasis
3. A five-protein prognostic signature with GBP2 functioning in immune cell infiltration of clear cell renal cell carcinoma
4. Pan-Cancer Proteomics Analysis Reveals Wiskott–Aldrich Syndrome Protein as a Potential Regulator of Programmed Death-Ligand 1
5. Immune cell patterns before and after neoadjuvant immune checkpoint blockade combined with chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
6. Comparison of RNAscope and immunohistochemistry for evaluation of the UPK2 status in urothelial carcinoma tissues
7. α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study
8. Mushroom extracts and compounds with suppressive action on breast cancer: evidence from studies using cultured cancer cells, tumor-bearing animals, and clinical trials
9. A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma
10. Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma
11. Supplementary Figures from CBX8 Exhibits Oncogenic Activity via AKT/β-Catenin Activation in Hepatocellular Carcinoma
12. Supplementary Tables from CBX8 Exhibits Oncogenic Activity via AKT/β-Catenin Activation in Hepatocellular Carcinoma
13. EFHD1 , a novel mitochondrial regulator of tumor metastasis in clear cell renal cell carcinoma
14. LINC00493‐encoded microprotein SMIM26 exerts anti‐metastatic activity in renal cell carcinoma.
15. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma
16. HBx‐mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis
17. Momordica Charantia lectin exhibits antitumor activity towards hepatocellular carcinoma
18. NORE1A sensitises cancer cells to sorafenib-induced apoptosis and indicates hepatocellular carcinoma prognosis
19. An E2F1/DDX11/EZH2 Positive Feedback Loop Promotes Cell Proliferation in Hepatocellular Carcinoma
20. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1
21. FMNL1 Exhibits Pro-Metastatic Activity via CXCR2 in Clear Cell Renal Cell Carcinoma
22. Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis
23. Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo
24. Immunophenotypes Based on the Tumor Immune Microenvironment Allow for Unsupervised Penile Cancer Patient Stratification
25. CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma
26. Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways
27. A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma
28. Role of Porcine Fibrin Sealant in the Prevention of Cervical Anastomotic Leakage After Esophagectomy for Esophageal or Esophagogastric Junction Cancer (PLACE020): A Phase 2, Single-Arm, Prospective Study
29. A Coiled‐Coil Domain Containing 50 Splice Variant Is Modulated by Serine/Arginine‐Rich Splicing Factor 3 and Promotes Hepatocellular Carcinoma in Mice by the Ras Signaling Pathway
30. Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways.
31. A GYS2/p53 negative feedback loop restricts tumor growth in HBV-related hepatocellular carcinoma
32. PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
33. CBX8 Exhibits Oncogenic Activity via AKT/β-Catenin Activation in Hepatocellular Carcinoma
34. Increased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinoma
35. Retracted: HB x‐mediated decrease of AIM 2 contributes to hepatocellular carcinoma metastasis
36. TRIM65 triggers β-Catenin signaling via ubiquitination of Axin1 to promote hepatocellular carcinoma
37. miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33
38. A Coiled‐Coil Domain Containing 50 Splice Variant Is Modulated by Serine/Arginine‐Rich Splicing Factor 3 and Promotes Hepatocellular Carcinoma in Mice by the Ras Signaling Pathway.
39. LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
40. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
41. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma
42. Abstract 3547: FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2
43. Momordica Charantia lectin exhibits antitumor activity towards hepatocellular carcinoma
44. FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2
45. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1
46. Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
47. Low SIRT3 Expression Correlates with Poor Differentiation and Unfavorable Prognosis in Primary Hepatocellular Carcinoma
48. Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis
49. Histone Deacetylase Inhibitors Facilitate Dihydroartemisinin-Induced Apoptosis in Liver Cancer In Vitro and In Vivo
50. HnRNPR-mediated UPF3B mRNA splicing drives hepatocellular carcinoma metastasis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.